Seth Lewis is Senior Vice President, Investor Relations, Communications and Strategy of Molecular Partners. His work includes global communications, shareholder relationship management and external strategy. Prior to joining Molecular Partners, Seth was Head of IR and Communications at Surface Oncology (NASDAQ: SURF) where he was integral in establishing the company’s communications strategy. Prior to Surface, he served as Vice President of IR and Communications at Bavarian Nordic, a Danish-listed, live-virus vaccine developer. He began his career in biotech with the Trout Group (now Solebury Trout), a boutique investor relations and strategic consultancy. Seth obtained a B.A. in history from Hartwick College in Oneonta, NY.